Taiwan FDA registration 734494ba6c1db833de5861a6deab5554

"Siemens" lipoprotein A-1 & B correction solution

TW: “西門子” 脂蛋白元A-1 & B校正液

Taiwan·Risk Class 2·RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.·Registered Nov 27, 2018 – Nov 27, 2028Active

Registration details

Analysis ID: 734494ba6c1db833de5861a6deab5554
Customs Code: DHA05603180801

Company information

Manufacturer: RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.
Manufacturer Country: United Kingdom;;United States
Authorized Representative: SIEMENS HEALTHCARE LIMITED

Product details

Intended Use: This product is intended for in vitro diagnostic use and can be used to correct APOA1 and APO B tests using Atellica CH Analyzer.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1150 Calibrated Products
Import Information: import

Dates and status

Registration Date: Nov 27, 2018
Expiry Date: Nov 27, 2028

About this record

Access comprehensive regulatory information for "Siemens" lipoprotein A-1 & B correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 734494ba6c1db833de5861a6deab5554 and manufactured by RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.